Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-10

Clinical Trial Update: Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of intravenous hyoscine butylbromide on labor in high-risk women completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Cairo University | Conditions: Vaginal Delivery | Phase 4 | Status: COMPLETED